M&A Deal Summary |
|
|---|---|
| Date | 2006-07-12 |
| Target | Visma |
| Sector | Information Technology |
| Buyer(s) |
HgCapital
Intermediate Capital Group |
| Deal Type | Going Private |
| Deal Value | 382M GBP |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Private Equity Firm |
|---|---|
| Founded | 2000 |
| PE ASSETS | 65.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
HgCapital is a European private equity firm focused on a wide range of transactions including public-to-private leveraged buy-outs, management buy-ins, divestitures, and turnarounds. Broad sectors of interest include consumer and leisure, healthcare, industrials, services, technology, media, and renewable energy. The Firm will consider both majority and minority investment positions. HgCapital is the successor to Mercury Capital Partners, a former unit of Merill Lynch which was spun out by management in 2000. HgCapital has offices in London and Munich.
| DEAL STATS | # |
|---|---|
| Overall | 30 of 138 |
| Sector (Information Technology) | 2 of 14 |
| Type (Going Private) | 3 of 8 |
| Country (Norway) | 1 of 4 |
| Year (2006) | 3 of 4 |
| Size (of disclosed) | 7 of 31 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-07-06 |
Castlebeck
County Durham, United Kingdom Castlebeck is a provider of specialist healthcare and rehabilitation services for adults and adolescents with learning disabilities and severely challenging behaviours. It operates specialist hospitals and care homes across the Midlands, North East of England and Scotland. |
Sell | £255M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-12-01 |
Schleich
Schwabisch Gmund, Germany Schleich GmbH is a producer of plastic toy figurines, such as farm and wildlife animals, historical characters and the Smurfs. Schleich GmbH products, trading under the highly recognized name Schleich-S, are sold in over thirty countries, including Germany, the US, the UK, and France. |
Buy | - |
| Category | Mezzanine Finance Firm |
|---|---|
| Founded | 1989 |
| PE ASSETS | 74.5B USD |
| Size | Mega |
| Type | Sector Agnostic |
Intermediate Capital Group (ICG) is a global mezzanine finance firm. IGC looks to provide junior capital to support a wide range of transactions, including buyouts, debt restructurings, and development financing. The Firm generally invests alongside financial sponsors and management teams in transactions valued from €250 million to €1 billion. ICG was formed in 1989 and is headquartered in London.
| DEAL STATS | # |
|---|---|
| Overall | 166 of 288 |
| Sector (Information Technology) | 3 of 6 |
| Type (Going Private) | 7 of 9 |
| Country (Norway) | 3 of 5 |
| Year (2006) | 16 of 22 |
| Size (of disclosed) | 34 of 82 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-07-01 |
Cerba European Lab
Saint-Ouen-l'Aumône, France Laboratoire CERBA SA is active in all three segments of the clinical pathology business, namely esoteric, routine and central lab. CEL operates in 34 locations across Europe, the United States, South Africa, Australia and China. It has a staff of over 1,300 employees, including 85 clinical pathologists and performs 85,000 tests daily. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-07-21 |
Sebia
Lisses, France Sebia is a provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic testing. Its systems analyse proteins in order to screen and monitor various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes and also Hemoglobinopathy and rare pathologies. Sebia was founded in 1967 and is headquartered in Lisses, France. |
Buy | - |
